Shi Y K, Sun Y
Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):68-72. doi: 10.3760/cma.j.issn.0253-3766.2019.01.012.
With the support of the national policies, the improvement of research ability and the development of economy and society, China clinical trials have developed rapidly. Many achievements are made in the clinical trials of new anti-cancer drugs during last several decades. Many innovative new drugs have come into the market and gained influence at home and abroad. Those drugs provide more treatment options for Chinese patients. This article reviews the results of new anti-tumor drug clinical trials, with special focus on the challenge and chance for the new anti-cancer drug clinical trials in China.
在国家政策的支持、研究能力的提升以及经济社会的发展下，中国的临床试验发展迅速。在过去几十年中，新型抗癌药物的临床试验取得了许多成果。许多创新新药已上市并在国内外产生影响。这些药物为中国患者提供了更多的治疗选择。本文回顾了新型抗肿瘤药物临床试验的结果，特别关注中国新型抗癌药物临床试验面临的挑战和机遇。
Zotero 插件